SUBLOCADEの長期的な成果
オピオイド使用障害(オピオイド依存症)の成人におけるSUBLOCADE(SUBUTEX徐放性)臨床転帰の第IV相縦断研究
This study will provide the opportunity to generate data on the long-term use of SUBLOCADE under real-world conditions, and to observe enduring changes in lifestyle, health, and sociodemographic factors that are part of the recovery process. Long-term patterns of abstinence/opioid misuse as well as measures of participants' physical, psychological, social, and economic well-being will be monitored to better understand factors associated with recovery from opioid use disorder (OUD). Therefore, this study will observe participants up to a maximum of 4 years.
調査の概要
状態
条件
詳細な説明
This is a Phase IV, prospective, multicentre, multinational, open-label, real-world observational study in participants with current or a history of OUD/opioid dependence.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
California
-
Costa Mesa、California、アメリカ、92626
- ATP Clinical Research
-
Escondido、California、アメリカ、92025
- Neighborhood Healthcare-Institute of Health
-
-
Connecticut
-
Westport、Connecticut、アメリカ、06880
- Elevate Health and Wellness
-
-
Florida
-
Hialeah、Florida、アメリカ、33012
- United Research Institute
-
Hollywood、Florida、アメリカ、33021
- Zenith Clinical Research LLC
-
Miami、Florida、アメリカ、33126
- Jackson Health Community Center
-
Miami、Florida、アメリカ、33134
- G+C Research Group
-
-
Georgia
-
Decatur、Georgia、アメリカ、30033-4004
- Atlanta VA Medical Center
-
-
Kansas
-
Kansas City、Kansas、アメリカ、66160
- University of Kansas Medical Center
-
Prairie Village、Kansas、アメリカ、66210
- Collective Medical Research.
-
-
Maine
-
Scarborough、Maine、アメリカ、04074-7163
- Maine Health
-
-
Maryland
-
Baltimore、Maryland、アメリカ、21229
- Maryland Treatment Centers
-
-
Massachusetts
-
Springfield、Massachusetts、アメリカ、01199
- Baystate Health
-
-
Michigan
-
Dearborn、Michigan、アメリカ、48124
- THRYV Clinical Studies
-
Dearborn Heights、Michigan、アメリカ、48127
- Vida Clinical Studies
-
Detroit、Michigan、アメリカ、48201
- Wayne State University Hospital
-
Fair Haven、Michigan、アメリカ、48023
- North Point Medical Center
-
Grand Rapids、Michigan、アメリカ、49503-4224
- SHMG Center for Integrative Medicine
-
-
Mississippi
-
Tupelo、Mississippi、アメリカ、38801
- North Mississippi Medical Center
-
-
Missouri
-
St Louis、Missouri、アメリカ、63141-8704
- Psych Care Consultants
-
-
New York
-
Amherst、New York、アメリカ、14226
- DENT Neurologic Institute
-
Binghamton、New York、アメリカ、13903
- United Health Services
-
New York、New York、アメリカ、10029
- Icahn School of Medicine at Mount Sinai
-
North New Hyde Park、New York、アメリカ、11042
- Core Clinical Trials
-
Rockville Centre、New York、アメリカ、11570
- Stuart Wasser Practice
-
-
North Carolina
-
Charlotte、North Carolina、アメリカ、28277
- Onsite Clinical Solutions LLC
-
-
Oklahoma
-
Oklahoma City、Oklahoma、アメリカ、73112
- Pahl Pharmaceutical Professionals LLC
-
-
Oregon
-
Corvallis、Oregon、アメリカ、97330
- Healing Comfort Clinic, LLC
-
-
Pennsylvania
-
Narberth、Pennsylvania、アメリカ、19072
- Thalia Medical Centre
-
-
South Carolina
-
Charleston、South Carolina、アメリカ、29407
- Charleston Pain and Rehabilitation Center
-
Columbia、South Carolina、アメリカ、29205
- Midlands Neurology
-
Greenville、South Carolina、アメリカ、29605
- Prisma Health
-
-
Texas
-
Houston、Texas、アメリカ、77043
- Biopharma Informatic, Inc. Research Center
-
-
Utah
-
Clinton、Utah、アメリカ、84015
- Alpine Research Organization
-
-
Virginia
-
Richmond、Virginia、アメリカ、23219
- Virginia Commonwealth University
-
-
-
-
-
Richmond、オーストラリア、VIC 3121
- Turning Point
-
-
Melbourne
-
Fitzroy、Melbourne、オーストラリア、3065
- St Vincent's Hospital Melbourne
-
-
New South Wales
-
Newcastle、New South Wales、オーストラリア、2300
- John Hunter Hospital
-
-
South Australia
-
Stepney、South Australia、オーストラリア、5069
- Drug and Alcohol Services South Australia (DASSA)
-
-
-
-
Alberta
-
Calgary、Alberta、カナダ、T2E2R2
- Smart Clinic
-
Edmonton、Alberta、カナダ、T5J 3E4
- Recovery Alberta
-
-
British Columbia
-
Surrey、British Columbia、カナダ、V3T 0H1
- Fraser Health Authority
-
-
Ontario
-
Burlington、Ontario、カナダ、L7M 4X9
- Dr. J.S. Dhillon Medicine Prof. Corp
-
Hamilton、Ontario、カナダ、L8N 1H3
- The Stipley Clinic
-
Owen Sound、Ontario、カナダ、N4K 6M9
- Brightshores Health System
-
Sarnia、Ontario、カナダ、N7T 5W9
- Bluewater Rapid Assessment Addiction Medicine Clinic
-
Toronto、Ontario、カナダ、M4J 1M3
- Comprehensive Treatment Clinic
-
-
-
-
-
Linköping、スウェーデン、58185
- Linkoping University Hospital, Psychiatry Center
-
Stockholm、スウェーデン、SE-11365
- Beroendecentrum
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Participants may enroll if they have initiated treatment with SUBLOCADE within 3 months prior to signing the informed consent form (ICF), or have completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and received their last dose of SUBLOCADE on the study within 3 months prior to signing the ICF, and plan to receive additional SUBLOCADE injections.
説明
Inclusion Criteria:
Participants must meet all of the following criteria:
-
Is an adult ≥ 18 years of age who has signed the informed consent form
-
Plans to receive additional SUBLOCADE injections and
-
Has initiated treatment for OUD/opioid dependence with SUBLOCADE within the last 3 months prior to Baseline Visit
- OR
-
Has completed an Indivior SUBLOCADE study (eg, INDV-6000-401, INDV-6000-405) and has received the last dose of SUBLOCADE on that study within 3 months prior to Baseline Visit
-
-
Is not currently participating in any clinical trial requiring medical intervention
-
Is not currently using opioids to treat a diagnosis other than OUD/opioid dependence
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Participants achieving DSM-5 remission, early or sustained, (yes/no) while on initial SUBLOCADE treatment by 6 months and 1, 1.5, 2, 2.5, and 3 years from study Baseline
時間枠:up to a maximum of 4 years
|
|
up to a maximum of 4 years
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Key Secondary: Participants with "no symptoms" or improving by ≥1 DSM-5 severity classification within the last 3 months (moderate to mild, or severe to mild or moderate) relative to study Baseline (yes/no) at Month 6 and Years 1, 2, and 3
時間枠:up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Among those starting SUBLOCADE within 3 months of study Baseline, time to achieve early remission for the first time while on initial SUBLOCADE treatment
時間枠:up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Participants achieving DSM-5 sustained remission (yes/no) by 1, 1.5, 2, 2.5, and 3 years while on initial SUBLOCADE treatment
時間枠:up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Time to achieve sustained remission for the first time while on initial SUBLOCADE treatment
時間枠:up to a maximum of 4 years
|
DSM-5-Related |
up to a maximum of 4 years
|
|
Time to discontinuing initial SUBLOCADE treatment and the corresponding reasons for discontinuation, eg, resolution of OUD symptoms, safety concerns, treatment failure, or seeking alternative MOUD treatment
時間枠:up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
Participants switching from initial SUBLOCADE treatment to another MOUD (yes/no), and the corresponding reasons, eg, safety concerns, treatment failure, seeking alternative MOUD treatment
時間枠:up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
The overall treatment duration for participants who stop initial SUBLOCADE treatment as the result of resolution of OUD symptoms
時間枠:up to a maximum of 4 years
|
MOUD Use and Retention |
up to a maximum of 4 years
|
|
Participants with any positive opioid use in the past month (yes/no) at Month 6 and Years 1, 2, and 3 while on initial SUBLOCADE treatment
時間枠:up to a maximum of 4 years
|
Illicit Opioid Use (Self-Reports) |
up to a maximum of 4 years
|
|
Participants with opioid overdose requiring intervention (yes/no) while on initial SUBLOCADE treatment at least once during the first 6 months, and during Years 1, 2, and 3
時間枠:up to a maximum of 4 years
|
Opioid Overdose Requiring Intervention |
up to a maximum of 4 years
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。